Ascend Laboratories, LLC recalls Ibuprofen and Famotidine Tablets 800mg/26.6mg, Rx Only, 90 Tablets per Bottle, manufactured by: Alkem Laboratories Ltd., INDIA,…
Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine.
Read the official notice →- Date
- 2024-01-24
- Country
- United States
- Brand
- Ascend Laboratories
- Product
- Ibuprofen and Famotidine Tablets 800mg/26.6mg, Rx Only, 90 Tablets per Bottle, manufactured by: Alkem Laboratories Ltd., INDIA,…
- Classification
- Class II
- Units
- Nationwide
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Ascend Laboratories recalls
- 2024-12-18
USAscend Laboratories, LLC recalls Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend…
CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
- 2024-10-02
- US
- 2024-02-28
- US
Ascend Laboratories, LLC recalls Fosfomycin Tromethamine Granules for Oral Solution, (equivalent to 3 grams of fosfomycin), single-dose sachet, Rx Only, Manufactured by:…
Failed Impurities/Degradation Specification: Out of specification for organic impurities
- 2023-09-13
- US
Ascend Laboratories, LLC recalls Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA,…
Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability.
- 2023-07-26
- US
- 2023-04-26
- US
Ascend Laboratories, LLC recalls Aripiprazole Tablets, USP, 20 mg, Rx Only, Packaged in 500-count bottle Manufactured by: Alkem Laboratories Ltd., INDIA Distributed by:…
Out of specification (OOS) for Spectroscopic Identification test by IR.
Other drugs & medical recalls in the United States
- 2024-01-24
- US
ROi CPS LLC recalls regard Operative LAP, Item Number 800943001; surgical convenience kit
Surgical convenience kits were manufactured with a component which was subsequently recalled by Nurse Assist.
- US
The Procter & Gamble Company recalls Secret OUTLAST Dry Spray, (Aluminum chlorohydrate 23.5%), Antiperspirant, Protecting Powder, Topical spray can 3.8 oz (107 g),…
CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
FDA · DrugThe Procter & Gamble CompanyNationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands,…Official notice → - US
The Procter & Gamble Company recalls Secret, powder fresh, Aluminum chlorohydrate 24%, Anti-Perspirant/Deodorant, Topical spray can Net Wt., (a) 4OZ (113g), NDC…
Chemical contamination: presence of benzene
FDA · DrugThe Procter & Gamble CompanyNationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands,…Official notice → - US
Insight Pharmaceuticals LLC, a Prestige Consumer… recalls Americaine, (benzocaine 20%) Benzocaine Topical Anesthetic Spray, Aerosol Can 2 oz (57 G), Dist. by Insight…
Chemical Contamination: presence of benzene
- US
Pfizer Inc. recalls 4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL…
Presence of Particulate Matter; identified as glass
- US
Par Sterile Products LLC recalls Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton,…
Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.